trending Market Intelligence /marketintelligence/en/news-insights/trending/zWDaO0wfEW1ptZDeLHIUGg2 content esgSubNav
In This List

CymaBay plans common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


CymaBay plans common stock offering

CymaBay Therapeutics Inc. plans to sell its common stock in an underwritten public offering.

The company intends to use the proceeds of the offering to fund ongoing development of seladelpar and for working capital and general corporate purposes.

JonesTrading Institutional Services LLC is acting as the sole book-running manager, with LifeSci Capital LLC as the lead manager for the offering.